Genmab A GMAB
NASDAQ GMAB
$39.57 +0.50 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genmab A (GMAB) Non-Current Deferred Tax Liability (2024 - 2026)

Updated

Genmab A (GMAB) reported Non-Current Deferred Tax Liability of $364 million for the quarter ended Jun 30, 2026, down 0.3% from the prior quarter.

Analysis

Genmab A (GMAB) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends

Dating back to the quarter ended Jun 30, 2024, Genmab A's Non-Current Deferred Tax Liability record includes 8 quarters.

  • By year, Non-Current Deferred Tax Liability came in at $330 million in the year ended Dec 31, 2024.
  • Five-year quarterly Non-Current Deferred Tax Liability spans a low of $169.15 million in the quarter ended Sep 30, 2024 and a high of $365 million in the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Genmab A 2.56 Bn -2.81 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 364.00 Mn
Mar 31, 2026 365.00 Mn
Dec 31, 2025 364.00 Mn
Sep 30, 2025 330.00 Mn
Jun 30, 2025 330.00 Mn
Mar 31, 2025 330.00 Mn
Dec 31, 2024 330.00 Mn
API Access

Genmab A Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=GMAB&period=max&api_key=YOUR_API_KEY